Literature DB >> 7888603

Griseofulvin absorption from different sites in the human small intestine.

T Gramatté1.   

Abstract

The site-dependent small-intestinal absorption pattern of griseofulvin was investigated in man. Griseofulvin was chosen as a model substance having extremely low water solubility and moderate lipid solubility. A conventional steady-state perfusion technique (triple-lumen tubing system with a 20 cm test segment) was applied. Dissolved griseofulvin (10.0 mg L-1) was perfused (10 mL min-1) during 160 min into different parts of the small intestine with the middle of the test segment between 85 cm and 270 cm beyond the teeth. Each of the ten healthy volunteers was examined twice with the test segment localized in different regions to allow for intraindividual comparisons. Mean drug absorption rates calculated from intestinal aspirate concentrations were similar in the two intestinal parts (proximal, 15.0 +/- 5.9 micrograms (20 cm min)-1; distal, 16.2 +/- 4.3 micrograms (20 cm min)-1; mean +/- SD). Absorption rate was strongly correlated to the amount of griseofulvin offered to the test segment per unit time. Extrapolating these findings it follows that an amount of griseofulvin, once dissolved, would be absorbed completely (> 99%) along 100 cm of the small intestine. A significant, positive correlation between the rate of transmucosal fluid transport and the absorption rate of griseofulvin was observed in the distal parts investigated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888603     DOI: 10.1002/bdd.2510150903

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  6 in total

1.  An integrated model for determining causes of poor oral drug absorption.

Authors:  L X Yu
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids.

Authors:  Eva M Persson; Ann-Sofie Gustafsson; Anders S Carlsson; Ralf G Nilsson; Lars Knutson; Patrick Forsell; Gunilla Hanisch; Hans Lennernäs; Bertil Abrahamsson
Journal:  Pharm Res       Date:  2005-10-30       Impact factor: 4.200

3.  Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog.

Authors:  A F Parr; E P Sandefer; P Wissel; M McCartney; C McClain; U Y Ryo; G A Digenis
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 4.  Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research.

Authors:  Stefan Senekowitsch; Philipp Schick; Bertil Abrahamsson; Patrick Augustijns; Thomas Gießmann; Hans Lennernäs; Christophe Matthys; Luca Marciani; Xavier Pepin; Alan Perkins; Maximilian Feldmüller; Sarah Sulaiman; Werner Weitschies; Clive G Wilson; Maura Corsetti; Mirko Koziolek
Journal:  Pharmaceutics       Date:  2022-04-06       Impact factor: 6.525

5.  Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.

Authors:  Peng Zhang; Jianqin Lu; Yixian Huang; Wenchen Zhao; Yifei Zhang; Xiaolan Zhang; Jiang Li; Raman Venkataramanan; Xiang Gao; Song Li
Journal:  AAPS J       Date:  2013-11-27       Impact factor: 4.009

6.  Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.

Authors:  Andrés Olivares-Morales; Hans Lennernäs; Leon Aarons; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2015-05-19       Impact factor: 4.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.